您的位置: 首页 > 农业专利 > 详情页

COMPOSITION PHARMACEUTIQUE POUR PRÉVENIR OU TRAITER DES TROUBLES CÉRÉBRAUX DÉGÉNÉRATIFS, CONTENANT HDL-APOM-S1P EN TANT QUE PRINCIPE ACTIF
专利权人:
Kyungpook National University Industry-Academic Cooperation
发明人:
申请号:
EP18839005.8
公开号:
EP3659584A1
申请日:
2018.07.11
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
The present invention relates to a novel use for HDL-ApoM-S1P (a high density lipoprotein in which apolipoprotein M is impregnated with sphingosine-1-phosphate), and more particularly, to using HDL-ApoM-S1P to prevent, improve, or treat degenerative brain disorders (in particular, Alzheimer's disease), cognitive disorders, learning disabilities, and memory disorders, and using HDL-ApoM-S1P to improve cognitive ability, learning ability, and memory.The HDL-ApoM-S1P according to the present invention not only alleviates neuroinflammation but also significantly exhibits improvement effects of cognitive disorder, learning disability, and memory disorder with respect to individuals suffering from degenerative brain disorders (in particular, Alzheimer's disease), and exhibits an effect of greatly reducing amyloid beta and tau deposition. Moreover, increased HDL-ApoM-S1P in the body also has an excellent effect of improving the cognitive, learning, and memory abilities of non-disabled individuals.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充